Skip to main content
. 2010 Jan;51(1):140–149. doi: 10.1194/jlr.M900273-JLR200

Fig. 5.

Fig. 5.

Statins and ezetimibe are associated with high levels of human plasma PCSK9 as a function of LDL-C reduction. Plasma PCSK9 levels of 139 hypercholesterolemic subjects were measured by ELISA as described. Hypercholesterolemic patients were being treated with one of the following: statins, ezetimibe, or a combination of both. The percent reduction in LDL-C was then plotted against PCSK9 levels (ng/ml). r and P were determined with GraphPad Prism software.